Exodus Point Capital Management, LP Akero Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 55,207 shares of AKRO stock, worth $2.62 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
55,207
Previous 47,632
15.9%
Holding current value
$2.62 Million
Previous $1.37 Million
12.36%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$350 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$326 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$286 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$265 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$248 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.2B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...